Company Filing History:
Years Active: 2016
Title: Andre Goy: Innovator in Hodgkin Lymphoma Research
Introduction
Andre Goy is a notable inventor based in New York, NY, who has made significant contributions to the field of oncology, particularly in the study of Hodgkin lymphoma. His innovative work focuses on identifying biomarkers that can predict clinical outcomes for patients suffering from this type of cancer.
Latest Patents
Goy holds a patent for a method involving Fibroblast Growth Factor-2 (FGF2) and Syndecan-1 (SDC1) as biomarkers for poor outcomes in Hodgkin lymphoma patients. The invention outlines a process for predicting the recurrence of Hodgkin lymphoma by analyzing RNA samples from patients and comparing them to control subjects. This method provides a crucial tool for clinicians in assessing the prognosis of Hodgkin lymphoma patients.
Career Highlights
Throughout his career, Andre Goy has worked with prominent institutions, including Hackensack University Medical Center. His research has focused on improving patient outcomes through innovative diagnostic methods and treatments.
Collaborations
Goy has collaborated with notable colleagues, including K Stephen Suh and Stephen Suh, to advance research in the field of Hodgkin lymphoma.
Conclusion
Andre Goy's contributions to cancer research, particularly through his patented methods for predicting Hodgkin lymphoma outcomes, highlight his role as an influential inventor in the medical field. His work continues to impact the lives of patients and the future of oncology.